Namenda (memantine) is a prescription drug used to treat dementia related to Alzheimer’s disease. Namenda comes as an oral tablet and an extended-release oral capsule. It’s a brand-name drug that’s ...

The Food and Drug Administration approved the German medication memantine today to help ease the severe symptoms of an estimated 1 million Americans who suffer from the late stages of Alzheimer's ...

Another earlier memantine trial – the Benefit and Efficacy in Severely Demented patients during Treatment with Memantine (M-Best or 9403) study – enrolled participants with moderately severe AD as ...

Deprescribing ChEIs/memantine can reduce the risk for ADRs and drug-drug and drug-disease interactions. It can also reduce the pill burden for patients and improve adherence to other medications, as ...

Clinical trials in Alzheimer disease (AD) generally allow participants to continue receiving concomitant medications, including cholinesterase inhibitors (ChEIs) and memantine, if the dose is stable.

Alzheimer's disease is the world's most common neurodegenerative disease, affecting more than 50 million people globally. Alzheimer's disease is also among the most fatal, landing as one of the top ...

Please provide your email address to receive an email when new articles are posted on . There are no FDA-approved medications for post-traumatic headache. Most patients reported treatment had a ...

Namenda (memantine hydrochloride) is a prescription drug used to treat moderate to severe Alzheimer’s disease. Namenda’s cost may depend on factors, including your dosage, whether you have health ...

Please provide your email address to receive an email when new articles are posted on . Response rates on the SRS-2 and CGI-S were significantly higher in those given memantine. Memantine was also ...

Olanzapine with or without an NK-1 receptor antagonist for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy: A phase III randomized, ...